LEXICON PHARMACEUTICALS, INC. Insider Trading for March 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LEXICON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LEXICON PHARMACEUTICALS, INC. for March 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | SANDS ARTHUR T | President & CEO | Option Exercise | M | 0.00 | 35,000 | 0 | 105,000 | |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | SANDS ARTHUR T | President & CEO | Option Exercise | M | 0.00 | 37,000 | 0 | 74,000 | |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | SANDS ARTHUR T | President & CEO | Option Exercise | M | 0.00 | 36,250 | 0 | 36,250 | |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | SANDS ARTHUR T | President & CEO | Payment of Exercise | F | 1.92 | 29,791 | 57,199 | 1,021,329 | 1.1 M to 1 M (-2.83 %) |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | SANDS ARTHUR T | President & CEO | Buy | M | 0.00 | 35,000 | 0 | 1,051,120 | 1 M to 1.1 M (+3.44 %) |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | SANDS ARTHUR T | President & CEO | Buy | M | 0.00 | 37,000 | 0 | 1,016,120 | 979.1 K to 1 M (+3.78 %) |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | SANDS ARTHUR T | President & CEO | Buy | M | 0.00 | 36,250 | 0 | 979,120 | 942.9 K to 979.1 K (+3.84 %) |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Pharmaceutical ... | Option Exercise | M | 0.00 | 16,500 | 0 | 49,500 | |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Pharmaceutical ... | Option Exercise | M | 0.00 | 17,500 | 0 | 35,000 | |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Pharmaceutical ... | Option Exercise | M | 0.00 | 16,250 | 0 | 16,250 | |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Pharmaceutical ... | Payment of Exercise | F | 1.92 | 18,668 | 35,843 | 146,350 | 165 K to 146.4 K (-11.31 %) |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Pharmaceutical ... | Buy | M | 0.00 | 16,500 | 0 | 165,018 | 148.5 K to 165 K (+11.11 %) |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Pharmaceutical ... | Buy | M | 0.00 | 17,500 | 0 | 148,518 | 131 K to 148.5 K (+13.36 %) |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Pharmaceutical ... | Buy | M | 0.00 | 16,250 | 0 | 131,018 | 114.8 K to 131 K (+14.16 %) |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP, Clin Dev and C ... | Option Exercise | M | 0.00 | 17,500 | 0 | 52,500 | |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP, Clin Dev and C ... | Option Exercise | M | 0.00 | 13,000 | 0 | 26,000 | |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP, Clin Dev and C ... | Payment of Exercise | F | 1.92 | 11,992 | 23,025 | 26,783 | 38.8 K to 26.8 K (-30.93 %) |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP, Clin Dev and C ... | Buy | M | 0.00 | 17,500 | 0 | 38,775 | 21.3 K to 38.8 K (+82.26 %) |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP, Clin Dev and C ... | Buy | M | 0.00 | 13,000 | 0 | 21,275 | 8.3 K to 21.3 K (+157.10 %) |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | ZAMBROWICZ BRIAN P | EVP, Chief Scientif ... | Option Exercise | M | 0.00 | 20,000 | 0 | 60,000 | |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | ZAMBROWICZ BRIAN P | EVP, Chief Scientif ... | Option Exercise | M | 0.00 | 21,500 | 0 | 43,000 | |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | ZAMBROWICZ BRIAN P | EVP, Chief Scientif ... | Option Exercise | M | 0.00 | 21,250 | 0 | 21,250 | |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | ZAMBROWICZ BRIAN P | EVP, Chief Scientif ... | Payment of Exercise | F | 1.92 | 18,186 | 34,917 | 278,703 | 296.9 K to 278.7 K (-6.13 %) |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | ZAMBROWICZ BRIAN P | EVP, Chief Scientif ... | Buy | M | 0.00 | 20,000 | 0 | 296,889 | 276.9 K to 296.9 K (+7.22 %) |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | ZAMBROWICZ BRIAN P | EVP, Chief Scientif ... | Buy | M | 0.00 | 21,500 | 0 | 276,889 | 255.4 K to 276.9 K (+8.42 %) |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | ZAMBROWICZ BRIAN P | EVP, Chief Scientif ... | Buy | M | 0.00 | 21,250 | 0 | 255,389 | 234.1 K to 255.4 K (+9.08 %) |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 6,000 | 0 | 18,000 | |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 6,750 | 0 | 13,500 | |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 7,500 | 0 | 7,500 | |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Payment of Exercise | F | 1.92 | 6,612 | 12,695 | 61,641 | 68.3 K to 61.6 K (-9.69 %) |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 6,000 | 0 | 68,253 | 62.3 K to 68.3 K (+9.64 %) |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 6,750 | 0 | 62,253 | 55.5 K to 62.3 K (+12.16 %) |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 7,500 | 0 | 55,503 | 48 K to 55.5 K (+15.62 %) |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Dev and C ... | Option Exercise | M | 0.00 | 17,000 | 0 | 51,000 | |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Dev and C ... | Option Exercise | M | 0.00 | 19,500 | 0 | 39,000 | |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Dev and C ... | Option Exercise | M | 0.00 | 18,750 | 0 | 18,750 | |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Dev and C ... | Payment of Exercise | F | 1.92 | 16,297 | 31,290 | 149,789 | 166.1 K to 149.8 K (-9.81 %) |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Dev and C ... | Buy | M | 0.00 | 17,000 | 0 | 166,086 | 149.1 K to 166.1 K (+11.40 %) |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Dev and C ... | Buy | M | 0.00 | 19,500 | 0 | 149,086 | 129.6 K to 149.1 K (+15.05 %) |
| Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Dev and C ... | Buy | M | 0.00 | 18,750 | 0 | 129,586 | 110.8 K to 129.6 K (+16.92 %) |